SkylinePro

IBB - Biotech ETF could offer good potential

Long
SkylinePro Updated   
NASDAQ:IBB   iShares Biotechnology ETF
IBB seems to have starting minor wave 5 up that could lead its price to the most probable target of 134.00. This sector should be be one of the good options to be in during the current market scenario. If prices crosses down 199.70, this analysis should be reviewed. FOLLOW SKYLINEPRO TO GET UPDATES.
Trade closed: target reached:
Prices reached 134.60 and should be start a correction to around the most probable target of 115.00. If prices crosses up 136, this scenario should be reviewed. See updated post

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.